Regulus Therapeutics
RGLS
#8242
Rank
S$0.24 B
Marketcap
$3.68
Share price
9.80%
Change (1 day)
21.86%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2023 (TTM): -$2.31

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.22. In 2022 the company made an earnings per share (EPS) of -$2.45 an increase over its 2021 EPS that were of -$4.30.

EPS history for Regulus Therapeutics from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.31-5.51%
2022-$2.45-43.12%
2021-$4.30-40.55%
2020-$7.23-50%
2019-$14.47-80.36%
2018-$73.65-57.8%
2017-$174.52-28.66%
2016-$244.6242.2%
2015-$172.02-14.84%
2014-$202.01156%
2013-$78.91-98.75%
2012-$6,315

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$4.60-307.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
$4.18-288.18%๐Ÿ‡ซ๐Ÿ‡ท France
$24.28-1,192.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.61-217.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$5.41 143.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.89-14.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.22-334.91%๐Ÿ‡บ๐Ÿ‡ธ USA